Looking into the horizon of CAR-T cell therapies
In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Mari...
8 Apr 202433min
Oncogenes in relation to immune responses
In our tenth episode of the “Immuno Oncology Talks”, we will discuss oncogenes in relation to immune responses with our guest, Professor Juha Klefström, from the Finnish Cancer Institute at the Unive...
16 Feb 202427min
Cancer Immunotherapy and the role of Microbiome
In our ninth episode of the “Immuno Oncology Talks”, we will discuss the rapidly evolving field of the microbiome in cancer immunotherapy with our guest, Professor Jeroen Raes, from the Department of ...
24 Jun 202327min
Cancer cell and gene therapies and the challenges to access the market
In our eight episode of the “Immuno Oncology Talks”, we will hear about the current challenges of getting cancer cell and gene therapies on the market from a health economic perspective. Our guest, Pr...
28 Mai 202329min
Therapeutic RNA vaccines in cancer Immunotherapy
This episode, the seventh of our “Immuno Oncology Talks”, will be covering “Therapeutic RNA vaccines in cancer immunotherapy”, with our two guests, Professor Karine Breckpot and Professor Kris Thielem...
29 Mar 202329min
Adoptive therapy with engineered T cell receptors
In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the N...
25 Jan 202329min
Targeting Neutrophils as effector cells in cancer therapy
The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in canc...
13 Des 202225min
